Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06105424 · ClinicalTrials.gov registry record · NA
BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability
A NA study of Smoking and Tobacco Use, sponsored by RAI Services Company.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT06105424 is a NA study of Smoking and Tobacco Use that has completed, run by RAI Services Company. The registered enrollment target is 21 participants, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06105424, a NA study of Smoking and Tobacco Use, has completed, sponsored by RAI Services Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a single-center, single-blind, four-cohort, 22-day ambulatory study during which up to 24 healthy adult subjects \[6 smokers (SMK), 6 moist snuff consumers (MSC), 6 vapers (VAP), and 6 non-tobacco consumers (NTC)\] will complete 3 measurements of lung permeability. Nasal epithelial cells, sputum, and blood samples will also be collected for current and future biomarker research.
Conditions Studied
Interventions
- PROCEDURE Lung Permeability Assessment
Study Locations (1)
Nebraska
- Celerion, Inc. - Lincoln
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2016-09-24 |
| Est. Completion | 2016-12-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06105424
The ClinicalTrials.gov registry entry for NCT06105424 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (95% lower). The listed sponsor is RAI Services Company, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Smoking appearing as the primary indexed condition, and to 1 intervention - of which Lung Permeability Assessment is the first listed.
NCT06105424 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.
Frequently Asked Questions
What is clinical trial NCT06105424 about?
NCT06105424 is a clinical study titled "BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability". This will be a single-center, single-blind, four-cohort, 22-day ambulatory study during which up to 24 healthy adult subjects \[6 smokers (SMK), 6 moist snuff consumers (MSC), 6 vapers (VAP), and 6 non-tobacco consumers (NTC)\] will complete 3 measurements of lung permeability. Nasal epithelial cell...
What is the current status of trial NCT06105424?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2016-09-24. Estimated completion is 2016-12-28.
What conditions does trial NCT06105424 study?
This clinical trial studies the following conditions: Smoking, Tobacco Use, Smoking, Tobacco.
What interventions are being tested in trial NCT06105424?
The interventions under investigation include: Lung Permeability Assessment (PROCEDURE).
Who is sponsoring clinical trial NCT06105424?
This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06105424 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
RECRUITING · NA
-
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
RECRUITING · NA
-
Take A Break - Rural
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.